-
Mashup Score: 0Wolters Kluwer Health - 10 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1A Vaccine for Pancreatic Cancer Treatment? - 12 month(s) ago
I have to say, this new paper is good news on the oncology front. It’s from researchers at Sloan-Kettering and BioNTech (among others) and presents the results of a small trial treating patients with pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC). This is another crack at the “personalized cancer therapy” idea and simultaneously at the “cancer vaccine” idea, and it’s fair…
Source: www.science.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0GitHub - zsethna/CloneTrack - 12 month(s) ago
Contribute to zsethna/CloneTrack development by creating an account on GitHub.
Source: GitHubCategories: Hem/Oncs, Latest HeadlinesTweet-
21. Sidebar – we think #CloneTrack can track any #vaccine expanded clones, so if interested 👉🏽https://t.co/FhMl1EJ8uy We found… #mRNAvaccine expanded T cells are - CD8’s (see paper; re: CD4’s > see discussion). - High magnitude (👇🏽can reach upto 10% of all blood T cells….!) https://t.co/e7UgmzL84X
-
-
Mashup Score: 1Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature - 12 month(s) ago
A phase I clinical trial of an adjuvant personalized mRNA neoantigen vaccine, autogene cevumeran, in patients with pancreatic ductal carcinoma demonstrates that the vaccine can induce T cell activity that may correlate with delayed recurrence of disease.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
27. Can #mRNAvaccine expanded T cells detect micrometastases? Interesting clinical vignette in Figure 4 👉🏽 here https://t.co/d1SgGgdVHq.
-
-
Mashup Score: 1
The supposed hidden camera video was released by conservative group Project Veritas
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5
This study uses a prospective cohort of essential and frontline workers in 6 US states with SARS-CoV-2 infection to examine associations between 2 or 3 doses of mRNA COVID-19 vaccine and attenuation of symptoms and viral RNA load across SARS-CoV-2 viral lineages.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Discover what fresh topics, speakers, and partners we have in store for the 2nd mRNA-Based Therapeutics Summit. View the full event guide.
Source: mRNA-Based Therapeutics SummitCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Data from the CDC and from a comparison of mRNA and inactivated vaccine add reassurance about risks in young people.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Flu Virus-Inspired Nanoparticles for mRNA Delivery | Medgadget - 2 year(s) ago
Researchers at the University of California San Diego developed a new delivery technique for mRNA. The method involves flu virus-inspired nanoparticles that can escape endosomes, the acidic vesicles that engulf and destroy materials that attempt to enter cells. The nanoparticles contain a protein receptor that allows them to unlock the endosomes and release the mRNA into the interior of…
Source: www.medgadget.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Previous SARS-CoV-2 exposure increased the odds of developing clinically significant symptoms following the first dose of a COVID-19 mRNA vaccine, researchers reported in JAMA Internal Medicine. “These vaccines can elicit greater local and systemic reactions in persons with prior SARS-CoV-2 infection,” Amanda K. Debes, PhD, MS, an assistant scientist in the department of international
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
Personalized mRNA vaccine combined with immunotherapy reduces the risk of death or recurrence by 44% in high-risk melanoma patients. This is a promising step towards tailored cancer treatments. #mRNAVaccine #Immunotherapy https://t.co/2n9qCgxXnH https://t.co/jkRB5mOSO8